Login to Your Account



Cangene Gets $362M Contract Under BioShield For Botulism

By Aaron Lorenzo


Friday, June 2, 2006
The U.S. government has contracted with the Canadian firm Cangene Corp. on a $362 million agreement for a botulism treatment, the first award for that potential bioterror agent. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription